Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1 H -pyrazole-5-carboxylate as an HIV-1 replication inhibitor - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue RSC Medicinal Chemistry Année : 2020

Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1 H -pyrazole-5-carboxylate as an HIV-1 replication inhibitor

Guillaume Prestat

Résumé

(ESI) available: [biology: experimental procedures, full results of the first screening, dose-response curves; chemistry: general procedures, compounds characterization, 1 H and 13 C NMR spectra]. See Inspired by the antiviral activity of known pyrazole-based HIV inhibitors, we screened our in-house library of pyrazole-based compounds to evaluate their in cellulo activity against HIV-1 replication. Two hits with very similar structures appeared from single and multiple-round infection assays to be non-toxic and active in a dose-dependent manner. Chemical expansion of their series allowed an in-depth and consistent structure–activity-relationship study (SAR) to be built. Further ADME evaluation led to the selection of 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1H-pyrazole-5-carboxylate with an advantageous pharmacokinetic profile. Finally, examination of its mode of action revealed that this compound does not belong to the three main classes of anti-HIV drugs, a feature of prime interest in the context of viral resistance.

Domaines

Chimie
Fichier principal
Vignette du fichier
Manuscript RSC revised version.pdf (956.31 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03030936 , version 1 (10-12-2020)

Identifiants

Citer

Jeanne Fichez, Cathia Soulié, Laurent Le Corre, Sophie Sayon, Stéphane Priet, et al.. Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1 H -pyrazole-5-carboxylate as an HIV-1 replication inhibitor. RSC Medicinal Chemistry, 2020, 11 (5), pp.577-582. ⟨10.1039/D0MD00025F⟩. ⟨hal-03030936⟩
125 Consultations
102 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More